Thyroid hormones (3,5,3'-triiodothyronine; T 3 and thyroxine; T 4 ) play an important role in the regulation of cell metabolism. The biological function of T 3 is mediated through thyroid hormone receptors (TRs), which bind to specific DNA segments (thyroid hormone response elements, TREs) in the regulatory regions of target genes, thus altering gene expression (1). Subsequently, thyroid hormone deficiency is characterized by major metabolic disturbancies, including lipid metabolism.
concerning HDL-C levels in hypothyroidism: HDL-C was reported to be normal (7) , increased (8 '10) or decreased (11) .
The influence of different genetic and environmental factors is very important in the regulation of lipid and lipoprotein metabolism. Therefore, studies investigating normal or pathological lipid metabolism have to be conducted in different populations. In the present study, we investigated the effect of disease and long-term L-T 4 replacement therapy on serum lipid profile in hypothyroid children from Montenegro. Serum concentrations of total cholesterol (TC), HDL--cholesterol (HDL-C), LDL-cholesterol (LDL-C) and triglycerides (TG) were measured in the patients before and after L-T 4 replacement. The same data sets were obtained for a group of 100 healthy children, matched according to age and gender. We also compared the extent of the L-T 4 effect on serum lipids found in patients divided according to their metabolic status and TSH levels.
Materials and Methods

Study population
Serum lipid profile was assessed in a population of 58 hypothyroid children (22 boys and 36 girls), attending the Institute of Children's Diseases, Clinical Centre of Podgorica. The patients were aged from 2 months to 18 years, since the age at which clinically overt hypothyroidism appeared depended on the severity of the defect. Analyses were performed on two occasions: (1) when diagnosis of hypothyroidism was established and (2) at follow-up examination, after long-term L-T 4 replacement therapy. The control group consisted of 100 healthy children, matched according to age and gender.
Metabolic status of hypothyroid children was assessed by endocrinologist at follow-up examination, based on characteristic clinical signs and symptoms, and the patients were thus classified as normo-, hypoor hypermetabolic.
Reagents and Procedures
Serum lipid profile analyses were carried out in blood samples collected after a 12-h fasting period. Serum was separated by centrifugation at 3000 rpm and fresh samples were analyzed. TC and TG were measured by standard enzymatic methods, using commercial reagent kits from Randox Laboratories Ltd. (Crumlin, United Kingdom). HDL-C was assayed by the same enzymatic method used for the TC measurement, after precipitation with phosphotungstic acid in the presence of magnesium ions. The concentration of LDL-C was calculated with the Friedewald's formula (12) . TSH levels were measured by time-resolved fluoroimmunoassay by DELFIA Û hTSH reagent kit from Wallac Oy (Turku, Finland).
Statistical Methods
All values were expressed as means ± SD. The patients and healthy controls were divided in five age groups. Comparison of serum lipid values between patients and control subjects, as well as between the values obtained in patient groups before and after therapy, was performed by Student's t-test. The significance of the difference between the lipid concentrations found in individual patients before and after L-T 4 replacement was assessed by using the paired Student t-test. The concentrations of serum lipids in the treated patients were also correlated with the corresponding TSH levels by linear regression analysis.
Results
The concentrations of serum lipids obtained in children with hypothyroidism before and during longterm L-T 4 replacement therapy as well as in healthy controls are shown in Table I . The LDL-C and TC values were most markedly affected by hypothyroid state: the values in the patients were on the average of 100% (LDL-C) and 54% (TC) higher than in the healthy children. TG concentrations were slightly higher (p<0.05) and HDL-C lower (p<0.02), but only in some age groups.
The effect of long-term L-T 4 replacement on LDL--C and TC was quantitatively most pronounced: the values obtained in patients after therapy were markedly lower than before therapy and did not differ significantly from the values found in the corresponding age groups of healthy children. Lower concentrations of HDL-C were obtained after L-T 4 replacement, but the differences between the values found before and after therapy were statistically significant only in children aged from 10 to 15 years (p<0.05). In the same age group of patients, replacement therapy induced a significant decrease of serum TG concentrations (p<0.005).
In order to compare the lipid-lowering effect of long-term L-T 4 replacement therapy in normometabolic versus hypometabolic patients, the concentrations of serum lipids in patients under long-term therapy were expressed as percents of the respective baseline values before therapy (Table II) . Marked effect of L-T4 administration of serum TC and LDL-C levels were found not only in normometabolic, but also in hypometabolic patients. However, significantly greater effect on TC and LDL-C values was found in the normometabolic than in hypometabolic group (p<0.01). The decrease in HDL-C levels induced by long-term L--T 4 administration was significant in both groups of patients (p<0.01). The drug effects mentioned above can be most clearly seen from data presented in Figure 1 , where the individual TC, HDL-C, LDL-C and TG levels obtained in the same patients before and after therapy, are shown.
We assessed the correlation between the concentrations of the measured serum lipid profile parameters and the corresponding TSH levels in hypothyroid children receiving long-term L-T 4 therapy. Good correlation was obtained between the TC and TSH values (y = 3.282 + 0.162x; r = 0.770; Figure 2 ), as well as between the LDL-C and TSH (y=1.689+0.149x; r=0.725) values. When the correlations of HDL-C vs. TSH and TG vs. TSH were tested, low correlation coefficients were obtained (r = ' 0.122 and r = 0.399, respectively). 
Discussion
Dyslipidaemia caused by thyroid hormone deficiency is associated with the increased risk of atherosclerosis (6) . Serum lipid profile in hypothyroidism is characterized by hypercholesterolaemia with a marked increase in LDL-cholesterol levels, but different results were obtained in different studies concerning HDL-C levels (7'11).
The patients included in this study were aged from 2 months to 18 years, since the age at which clinically overt hypothyroidism appeared was dependent on the severity of the disease. As serum lipid profile change with age, TC, HDL-C, LDL-C and TG concentrations obtained in the patients before L-T 4 administration were compared with the corresponding values found in the age-matched healthy controls (Table I) . TC and LDL-C values were most markedly affected by hypothyroid state: the values in the patients were on the average of 54% (TC) and 100% (LDL-C) higher than in healthy children. In most patients, this increase was sufficient to reach high-risk TC and LDL-C levels: >5.15 mmol/L and >3.37 mmol/L, respectively (13). The effect of the disease on serum TC and LDL--C concentrations was reversed by L-T 4 treatment: the values obtained in the treated patients were markedly lower than the levels before L-T 4 administration, and did not differ significantly from the corresponding values found in healthy children (Table I) . Our findings agree with the results of other authors: hypercholesterolaemia and a marked increase of LDL-C are typically found in hypothyroid individuals (2, 6, 8, 9, 14) . It is well-known that the transcription of the HMG-CoA reductase gene is activated by thyroid hormones (2'5). As HMG-CoA reductase is the rate-limiting enzyme in the cholesterol synthesis pathway, lower cholesterol synthesis rate is expected in hypothyroidism. However, LDL-receptor gene is also one of the thyroid hormone target genes. Although cholesterol synthesis is impaired in hypothyroid state, this effect is overwhelmed by a markedly decreased fractional clearance of LDL particles because of a reduced number of LDL receptors in the liver (2, 3) . This leads to LDL accumulation and high serum TC and LDL-C concentrations. Our finding that the cholesterol-lowering effect of L-T4 replacement therapy was significantly greater in normometabolic than in hypometabolic patients (Table II, Figure 1 ) can also be explained in terms of the mechanism described above: L-T4 administration fully restored LDL-receptor synthesis in normometabolic, but uncompletely in hypometabolic patients. In normometabolic children, TC and LDL-C concentrations after L-T 4 replacement were in the range of recommended values (Figure 1 ) : <4.4 mmol/L and <2.85 mmol/L, respectively (13) . However, this could be achieved only in a minority of hypometabolic children.
TC and LDL-C concentrations obtained in the patients treated with L-T 4 correlated well with the corresponding TSH levels (Figure 2 ). Significant associations with TSH were reported for TC and LDL-C by other authors as well (3, 15) and have been variously attributed to suboptimal therapy and/or an abnormal setting of the T4 negative feedback control of pituitary TSH secretion (16 '18) . Further investigations are needed to explain which of the two mechanisms caused the persistence of elevated TSH values in some of the L-T 4 -treated children included in this study.
In the oldest group (15.1'18 years), HDL-C was significantly lower in the patients, but the patients/controls differences were not significant in other age groups. Conflicting results appeared in the literature concerning HDL levels in hypothyroidism. Verdugo et al. (7) found normal HDL-C values in hypothyroid women, Agdeppa et al. (11) reported decreased values in hypothyroidism, whereas the increase of HDL-C concentration was observed in several studies (8 '10) . In any case, the influence of thyroid hormone deficiency on serum HDL-C levels is not so marked as the effect on LDL-C and TC values. However, there is evidence that the composition of HDL particles is altered in hypothyroid state (4, 5) . The effect is mediated through the regulation of CETP and HL genes expression by thyroid hormones. Tan et al (5) have shown for the first time that the concentration of HDL particles containing only apo A-I (LpA-I) was increased in hypothyroidism. As LpA-I is more antiatherogenic than LpA-II (19) , its increase in hypothyroid individuals might partly counteract the harmful effect of raised LDL-C.
Slightly higher TG concentrations were found in patients than in healthy children, but only in some age groups, whereas no significant differences were found in the others (Table I ). This is in agreement with the findings of other authors: TG and VLDL levels in hypothyroidism are normal or sometimes elevated (2), because of decreased lipoprotein lipase activity and a consequent slower rate of VLDL catabolism (20) . However, the extent of this effect is not always sufficient to produce a statistically significant difference between the TG values found in healthy and hypothyroid individuals, or before and after L-T 4 treatment.
In conclusion, hypothyroidism caused a marked increase in serum TC and LDL-C concentrations in the population of children from Montenegro, reaching the values associated with high risk of atherosclerosis. Long-term L-T 4 replacement therapy reversed this effect, especially in normometabolic children and those with lower THS values.
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